Physician profile
Emanuel E Nearing
NPI 1346564390
$15,191.78
in general payments reported to CMS, 2019-2025
8 companies · $73.72 in 2025
The $73.72 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $779 · 2020: $99.51 · 2021: $8,300 · 2022: $601 · 2023: $5,309 · 2024: $29.24 · 2025: $73.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,293 · Food and Beverage: $734 · Travel and Lodging: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,292.98 |
| Food and Beverage | $733.57 |
| Travel and Lodging | $385.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,439.72 | 2020-2025 | Davinci Xi, Da Vinci Surgical System |
| Medical Device Business Services, INC. | $963.53 | 2019-2023 | Echelon Flex, Harmonic |
| Medtronic, INC. | $341.26 | 2021-2025 | Signia |
| Ethicon US, LLC | $317.76 | 2021-2023 | Linx Reflux Management System, Echelon; Endopath |
| Alnylam Pharmaceuticals INC. | $68.88 | 2022 | |
| Tela Bio, INC. | $30.67 | 2022-2024 | Ovitex 2s |
| Teleflex LLC | $15.07 | 2024 | Titan Sgs |
| Kci USA, INC. | $14.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emanuel Nearing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.